Researchers are developing artificial lung devices designed for short-term and long-term use by patients with lung disease and patients who are waiting for donor lungs. However, challenges include a lack of understanding of resistance to blood flow and the need for advancements in plastics, MC3 CEO Scott Merz said.

Related Summaries